Abstract
Background:
This systematic review paper aims to study the experimental and human studies on the relationship between metabolic syndrome (MetS), its component and selenium (Se) concentration.
Materials and Methods:
The literature was searched in PubMed, Scopus, and Google Scholar databases with no time limitation using MetS X and Se key words in medical subject heading. The related papers were selected in three phases. After quality assessment, two reviewers extracted the data, whereas the third reviewer checked their extracted data. All evidence comes from experimental and laboratory studies.
Results:
Finally, 18 articles were included. While, some studies documented that as an antioxidant agent, Se might be correlated with endothelial function, large controversy exists about the type of correlation including positive, negative, and no correlation between MetS and Se levels in body. Some of the reviewed studies were focused on antioxidant supplementation effects on MetS, results also varied in this regard.
Conclusion:
This inconsistency could be because of diversity in study design, population, lack of special focus on Se and MetS, and finally the complex nature of MetS.
Keywords: Selenium, metabolic syndrome, prevention, systematic review
INTRODUCTION
Metabolic syndrome (MetS) has become a major global disease,[1] it represents a clustering of abnormalities typically involving abdominal obesity, insulin resistance, dyslipidemia, and hypertension.[2] MetS is common[3,4,5] and its risk increases with age.[4]
In addition, various other abnormalities of uric acid, inflammation, hemostasis, and fibrinolysis are often considered part of this syndrome. Not surprisingly, people with the MetS are at high-risk for developing diabetes and cardiovascular diseases.[6,7,8,9,10] Oxidative stress may also play a role in the pathophysiology of diabetes and cardiovascular disease.[11,12]
The role of inflammation and oxidative stress on several chronic diseases is receiving increasing attention because of their links with atherosclerosis, obesity, or type 2 diabetes mellitus[13,14] cause-effect relationships between inflammation, oxidative stress, and disease are not clear; but several studies associate features of MetS with higher concentrations of inflammatory biomarkers.[15,16]
Furthermore, recent findings indicate that elevated levels of adipokines and acute-phase inflammatory markers are associated with some manifestations accompanying features of MetS (adiposity, insulin resistance, dyslipidemia, etc.), and an increased risk for cardiovascular disease.[17,18,19]
If antioxidants play a protective role in the pathophysiology of diabetes and cardiovascular diseases, understanding the physiological status of antioxidant concentrations among people at high-risk for developing these conditions, as individuals with MetS, is of interest. However, little is known about this topic. Because the prevalence of obesity, which is associated with decreased concentrations of antioxidants,[20] is high among people with MetS, they are probably more likely to have low antioxidant concentrations.
On the other hand, epidemiological studies have shown that selenium (Se) is a protective factor against cardiovascular diseases.[21,22] Its protective ability is considered due to the fact that Se has anti-inflammatory and antioxidant properties.[23,24] Furthermore, the inverse correlation between serum Se and high-sensitive C-reactive protein (CRP) indicates that low Se level may be associated with oxidative stress, which may cause lipid peroxidation.[25]
Se considered as a micronutrient and is an essential trace element in human metabolism. New researches have shown a pivotal role for this element in human health.[26] Se has antioxidant and anti-inflammatory role through glutathione peroxidase (GPx) which can reduce hydrogen peroxide, lipid and phospholipid hydroperoxides, radicals, and reactive oxygen species.[27] This trace element may have a protective role against cardiovascular disease due to the ability of GPx to reduce the oxidative modification of lipids and to decrease platelet aggregation.[28] Because Se is normally found in significant amounts in immune tissues and has many effects on immune system, deficiency of Se is accompanied by loss of immunocompetence.[27,29,30]
Many dietary and lifestyle factors may contribute to increasing risk of developing MetS and cardiovascular disease,[31] and oxidative stress, and low antioxidant status may be associated with the unfavorable metabolic pattern. Available data are inconsistent.
Race, study design, animal or human studies, and different characteristics of participants such as sex, age, and body weight are other factors that influence differences in the findings obtained in various studies. This study aims to review the findings of human studies on the association of Se with MetS.
MATERIALS AND METHODS
Literature search
The search was conducted using Medline, Scopus, and Google Scholar databases to May 24, 2014. We search in the Medline literature database through PubMed and In PubMed, we used the medical subject heading.
Keywords including as MetS X and Se were used. The search was refined to the English language on human studies. We did not consider any time limitation. For any additional pertinent studies, the reference list of all relevant papers was screened as well. The process of selecting studies is depicted in Figure 1.
Figure 1.

Papers search and review flowchart for selection of primary study
The methodological quality of each eligible paper was assessed using a checklist based on guidelines provided in an earlier study,[32] in which papers were assigned up to a total score of 8 for fulfilling the main issues in prevalence studies, including sampling, measurements, and analysis.
Titles and abstracts of papers were screened and relevant papers were selected and duplicates were removed. Then, full texts of relevant papers were read, and findings were rescreened. Two independent (MK and MT) reviewers screened titles and abstracts of papers identified by the literature searches for their potential relevance or assessed the full text for inclusion in the review. In the case of disagreement, and the discrepancy was resolved in consultation with a third arbitrating investigator (RK).
Data extraction and abstraction
Two reviewers abstracted the data independently. The required information that was extracted from all eligible papers was as follows: Data on first author's last name, year of publication and country of the study population, the study name, study design characteristics, study population, type of study, aim, and finding of studies.
RESULTS
Pizent et al. in 2010 in Croatia demonstrated that MetS has no correlation with serum Se, zinc (Zn) and copper (Cu) concentration and superoxide dismutase and catalase activity. Higher GPx was found in subjects with MetS as well as in individuals with hypertriglyceridemia, and Cu concentration shown a significant correlation with CRP.[33] Hughes et al. in 1998 in Singapore showed that in both genders people with noninsulin-dependent diabetes mellitus had higher mean body mass indices, waist-hip ratios, and abdominal diameters. Higher prevalence of hypertension, higher mean levels of fasting serum triglyceride, slightly lower mean levels of serum high-density-lipoprotein (HDL) cholesterol, and higher mean levels of plasma plasminogen activator inhibitor-1 and tissue plasminogen activator. These factors are components of MetS and increase the risk of atherosclerosis and thrombosis. However, no important differences existed for plasma Vitamins A, C, and E, and especially in this case, serum Se, which are anti-oxidants.[32] Ford et al. in a cross-sectional study in 2003 evaluated antioxidant status among individuals from United States with MetS who were at high-risk for developing these conditions, data revealed from this study showed that adults with MetS have suboptimal concentrations of several antioxidants, which may partially explain their increased risk for diabetes and cardiovascular diseases and no significant differences existed in the concentrations of serum Se.[33]
Vidovic et al. in 2013 showed that the plasma Se level correlated positively with MetS, waist circumference, plasma glucose, and triglyceride concentration in Serbian patients with schizophrenia. In contrast, plasma Zn did not correlate with any of the MetS components[34] Obeid et al. in 2008, evaluated the relation between the status of plasma Zn, Cu, and Se, especially in terms of their relation to the components of MetS in a cross-sectional study in Lebanon. Their data revealed that plasma Se levels correlated positively with all MetS components.[35] Arnaud et al. in 2012 in a cross-sectional study investigated the relationships between plasma Cu, Zn, and Se concentrations and MetS in France. Results indicated gender differences in the association between plasma Se concentration and MetS without diabetes; they suggested a subclinical deleterious effect of high Se concentrations in women.[36]
Puchau et al., in four different studies from 2009 to 2010 in Spain, evaluated the associations between serum complement factor 3 (C3) and several anthropometric, biochemical and lifestyle features in healthy young adults, emphasizing on the putative effect of Se intake on C3 concentrations, potential associations between nail trace elements and several indicators in healthy young adults focusing on the effect of antioxidant trace element intake on inflammation-related marker concentrations, potential associations among dietary total antioxidant capacity and several early MetS manifestations and potential associations between serum asymmetric dimethylarginine (ADMA) and several anthropometric, biochemical, and lifestyle features in healthy young adults. These studies showed a possible role for Se intake in the modulation of C3; its assessment may be an early marker of the MetS manifestations.[37] Nail content on some trace elements related to antioxidant defense mechanisms seems to be associated with several inflammation-related markers linked to chronic diseases in apparently healthy young adults,[38] negative and significant associations between MetS and Se intake.[39] ADMA seems to be related with Se status and several anthropometric and biochemical measurements linked to MetS in apparently healthy young adults. These findings support a role for antioxidant/trace element intake in the modulation of ADMA; its assessment may be a marker for MetS.[40] Mutakin, et al. in 2013, conducted a cross-sectional study that aimed to examine the possible correlation between Se nutritional status and metabolic risk factors in men with visceral obesity in Indonesia. It showed that negative association between Se nutritional status and metabolic risk factors is limited to a particular group of obese men with or without MetS.[41]
Ghayour-Mobarhan et al. in 2008 evaluated the serum concentrations of Se and GPx concentrations in Caucasian patients with obesity and MetS in the United Kingdom. They found that the clinic patients had a significantly higher dietary intake of total fat, protein and Se compared with the healthy individuals. Patients also had significantly higher serum Se and lower serum GPx concentrations compared to the healthy individuals. Among the patients, obese subjects had significantly higher serum concentrations of Se and lower serum GPx. Moreover, within this group, serum Se concentrations decreased significantly with accumulating features of MetS. The lower levels of serum GPx in obesity and lower concentrations of serum Se associated with accumulating features of MetS may be related to the presence of an atherosclerosis prone state with an increased consumption of antioxidants by free radical interaction.[42] Skroza et al. in 2013 evaluated the role of a nutraceutical containing Q10 coenzyme, krill-oil, lipoic acid, resveratrol, Vitis vinifera seed oil, Vitamin E, and Se in addition to etanercept therapy for patients affected by psoriasis and MetS in an open-label randomized controlled study in Italy. Although the role of confounding factors in this study were not eliminated, revealed data showed statistically significant differences in HDL cholesterol and triglycerides concentrations.[43] Moreover, Zulet et al. in 2009 conducted an observational study that evaluated the potential relationships between serum sialic acid (SA) a levels, MetS features, and dietary Se intake in Spain to test the hypothesis that this antioxidant micronutrient may also have anti-inflammatory properties in healthy young adults. It showed that subjects with higher dietary Se intake showed significantly lower SA levels compared with subjects with lower dietary Se intake, while dietary Se negatively correlated with SA and recommended Se as a potential anti-inflammatory nutrient.[37] Contrary to the results of these two papers, Czernichow et al. in 2009, during a clinical trial study in France examined the effect of antioxidant supplementation for 7.5 years on the incidence and the epidemiologic association between baseline serum antioxidant concentrations and the prospective risk of MetS. This longitudinal study showed that antioxidant supplementation for a period of 7.5 years did not affect the risk of MetS.[44] In addition, Basu et al. in 2013 during a clinical trial showed that Se was not affected by green tea supplementation in cases with MetS in the United States.[45] Silva et al. investigated the relationship between habitual physical activity and dietary intake, body composition, metabolic and hormonal variables, and cardiovascular risk factors in Brazilian postmenopausal women with no evidence of cardiovascular disease in 2013. The results showed that active women had higher protein, total fat, cholesterol, iron, calcium, and the antioxidant micronutrients Zn and Se intake.[46] Perez-Cornago et al. in 2014, evaluated the association between dietary intake of water, fiber, Vitamin B6, ascorbic acid, tryptophan, magnesium, and Se with mood state in subjects with MetS in Spain. The results showed those participants who consumed more water, fiber, Vitamin B6, ascorbic acid, tryptophan, magnesium, and Se had higher mood.[47]
Summary of the studies on the association of Se and MetS are shown in Table 1.
Table 1.
Summary of the association of Se and MetS

DISCUSSION
In recent years, along the prevalence of adolescent obesity, the rate of MetS incidence increased dramatically[48,49] and diet is the one of most important factor in this increased incidence.[50] Micronutrients are considered as an essential part of the diet which have an important role in metabolism regulation.[51] Se is an essential micronutrient and has multiple roles in metabolism homeostasis. Particularly, in normal concentrations Se has an adverse effect on oxidant species and consequently has a protective role against cardiovascular disease.[26] On the other hand, MetS is one of the important causes of cardiovascular diseases.[48]
In the current study, we provided and summarized the information about the relationship between MetS components and Se as a trace element. The evidence comes from experimental studies.
As mentioned before, Se is considered as an antioxidant agent and its expected the concentration of this element be found correlated with endothelial function. Some studies support the hypothesis that Se levels have no correlation with MetS.[33,34,35]
However, some other studies support the hypothesis which Se levels have a positive correlation with MetS.[36,37,38]
Controversy exists between results obtained from studies on the correlation of MetS and Se levels are complete when the some other studies suggest that Se has a negative correlation with MetS.[39,40,41,42,43]
The controversy between results also seen in another type of studies, the effect of Se together other antioxidants on metabolic profile and health was evaluated in some of the clinical trials. The results of these studies were different too.[37,44,45,46,47]
Furthermore, the relation between lifestyle, MetS, Se status and the psychological state has been studied in two independent studies, the results from both of studies showed a positive correlation between the quality of life and Se status.[48,49]
CONCLUSION
Large controversies exist about the effects and correlation of Se on a component of MetS, which may be due to differences in study designing and population. In addition, there are a few articles focused specifically on Se and MetS. Instead, many confounding factors were included in these papers. This controversy in the study findings could also be because of the complex and multifactorial nature of MetS, and different definitions used for this disorder.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
AUTHOR'S CONTRIBUTION
All authors contributed in the study concept and design, assisted in the literature review, and drafting the paper. All authors have read the final version of the paper and accept the responsibility for its content.
REFERENCES
- 1.Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28. doi: 10.1016/S0140-6736(05)66378-7. [DOI] [PubMed] [Google Scholar]
- 2.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285:2486–97. doi: 10.1001/jama.285.19.2486. [DOI] [PubMed] [Google Scholar]
- 3.Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon H, et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis. 2006;186:345–53. doi: 10.1016/j.atherosclerosis.2005.07.021. [DOI] [PubMed] [Google Scholar]
- 4.Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–9. doi: 10.1001/jama.287.3.356. [DOI] [PubMed] [Google Scholar]
- 5.Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the middle east: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32:1092–7. doi: 10.2337/dc08-1800. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X) Diabetes. 1992;41:715–22. doi: 10.2337/diab.41.6.715. [DOI] [PubMed] [Google Scholar]
- 7.Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9. doi: 10.2337/diacare.24.4.683. [DOI] [PubMed] [Google Scholar]
- 8.Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16. doi: 10.1001/jama.288.21.2709. [DOI] [PubMed] [Google Scholar]
- 9.Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: A population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol. 1998;148:958–66. doi: 10.1093/oxfordjournals.aje.a009572. [DOI] [PubMed] [Google Scholar]
- 10.Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104–9. doi: 10.1001/archinte.159.10.1104. [DOI] [PubMed] [Google Scholar]
- 11.Oberley LW. Free radicals and diabetes. Free Radic Biol Med. 1988;5:113–24. doi: 10.1016/0891-5849(88)90036-6. [DOI] [PubMed] [Google Scholar]
- 12.Rao AV. Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med (Maywood) 2002;227:908–13. doi: 10.1177/153537020222701011. [DOI] [PubMed] [Google Scholar]
- 13.Brenneisen P, Steinbrenner H, Sies H. Selenium, oxidative stress, and health aspects. Mol Aspects Med. 2005;26:256–67. doi: 10.1016/j.mam.2005.07.004. [DOI] [PubMed] [Google Scholar]
- 14.Fulop T, Tessier D, Carpentier A. The metabolic syndrome. Pathol Biol (Paris) 2006;54:375–86. doi: 10.1016/j.patbio.2006.07.002. [DOI] [PubMed] [Google Scholar]
- 15.Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4–7. doi: 10.1016/j.it.2003.10.013. [DOI] [PubMed] [Google Scholar]
- 16.Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448–54. doi: 10.1161/01.CIR.0000158483.13093.9D. [DOI] [PubMed] [Google Scholar]
- 17.Guzik TJ, Mangalat D, Korbut R. Adipocytokines – Novel link between inflammation and vascular function? J Physiol Pharmacol. 2006;57:505–28. [PubMed] [Google Scholar]
- 18.Puchau B, Zulet MA, González de Echávarri A, Navarro-Blasco I, Martínez JA. Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults. Eur J Clin Nutr. 2009;63:858–64. doi: 10.1038/ejcn.2008.48. [DOI] [PubMed] [Google Scholar]
- 19.Zulet MA, Puchau B, Navarro C, Martí A, Martínez JA. Inflammatory biomarkers: The link between obesity and associated pathologies. Nutr Hosp. 2007;22:511–27. [PubMed] [Google Scholar]
- 20.Reitman A, Friedrich I, Ben-Amotz A, Levy Y. Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity. Isr Med Assoc J. 2002;4:590–3. [PubMed] [Google Scholar]
- 21.Beaglehole R, Jackson R, Watkinson J, Scragg R, Yee RL. Decreased blood selenium and risk of myocardial infarction. Int J Epidemiol. 1990;19:918–22. doi: 10.1093/ije/19.4.918. [DOI] [PubMed] [Google Scholar]
- 22.van de Vijver LP, Kardinaal AF, Grobbee DE, Princen HM, van Poppel G. Lipoprotein oxidation, antioxidants and cardiovascular risk: Epidemiologic evidence. Prostaglandins Leukot Essent Fatty Acids. 1997;57:479–87. doi: 10.1016/s0952-3278(97)90432-4. [DOI] [PubMed] [Google Scholar]
- 23.Steinbrenner H, Sies H. Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta (BBA) Gen Subj. 2009;1790:1478–85. doi: 10.1016/j.bbagen.2009.02.014. [DOI] [PubMed] [Google Scholar]
- 24.Rayman MP. Food-chain selenium and human health: Emphasis on intake. Br J Nutr. 2008;100:254–68. doi: 10.1017/S0007114508939830. [DOI] [PubMed] [Google Scholar]
- 25.Molnar J, Garamvolgyi Z, Herold M, Adanyi N, Somogyi A, Rigo J., Jr Serum selenium concentrations correlate significantly with inflammatory biomarker high-sensitive CRP levels in Hungarian gestational diabetic and healthy pregnant women at mid-pregnancy. Biol Trace Elem Res. 2008;121:16–22. doi: 10.1007/s12011-007-8018-2. [DOI] [PubMed] [Google Scholar]
- 26.Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–41. doi: 10.1016/S0140-6736(00)02490-9. [DOI] [PubMed] [Google Scholar]
- 27.Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium's role in the immune system. Ann N Y Acad Sci. 1990;587:123–39. doi: 10.1111/j.1749-6632.1990.tb00140.x. [DOI] [PubMed] [Google Scholar]
- 28.Nève J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 1996;3:42–7. [PubMed] [Google Scholar]
- 29.Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res. 1994;41:115–27. doi: 10.1007/BF02917222. [DOI] [PubMed] [Google Scholar]
- 30.Guimarães MJ, Peterson D, Vicari A, Cocks BG, Copeland NG, Gilbert DJ, et al. Identification of a novel selD homolog from eukaryotes, bacteria, and archaea: Is there an autoregulatory mechanism in selenocysteine metabolism? Proc Natl Acad Sci U S A. 1996;93:15086–91. doi: 10.1073/pnas.93.26.15086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Esposito K, Ciotola M, Maiorino MI, Giugliano D. Lifestyle approach for type 2 diabetes and metabolic syndrome. Curr Atheroscler Rep. 2008;10:523–8. doi: 10.1007/s11883-008-0081-4. [DOI] [PubMed] [Google Scholar]
- 32.Hughes K, Choo M, Kuperan P, Ong CN, Aw TC. Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: A population-based survey among Asians in Singapore. Atherosclerosis. 1998;136:25–31. doi: 10.1016/s0021-9150(97)00180-9. [DOI] [PubMed] [Google Scholar]
- 33.Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: Findings from the third National Health and Nutrition Examination Survey. Diabetes. 2003;52:2346–52. doi: 10.2337/diabetes.52.9.2346. [DOI] [PubMed] [Google Scholar]
- 34.Vidovic B, Dordevic B, Milovanovic S, Škrivanj S, Pavlovic Z, Stefanovic A, et al. Selenium, zinc, and copper plasma levels in patients with schizophrenia: Relationship with metabolic risk factors. Biol Trace Elem Res. 2013;156:22–8. doi: 10.1007/s12011-013-9842-1. [DOI] [PubMed] [Google Scholar]
- 35.Obeid O, Elfakhani M, Hlais S, Iskandar M, Batal M, Mouneimne Y, et al. Plasma copper, zinc, and selenium levels and correlates with metabolic syndrome components of lebanese adults. Biol Trace Elem Res. 2008;123:58–65. doi: 10.1007/s12011-008-8112-0. [DOI] [PubMed] [Google Scholar]
- 36.Arnaud J, de Lorgeril M, Akbaraly T, Salen P, Arnout J, Cappuccio FP, et al. Gender differences in copper, zinc and selenium status in diabetic-free metabolic syndrome European population – The IMMIDIET study. Nutr Metab Cardiovasc Dis. 2012;22:517–24. doi: 10.1016/j.numecd.2010.09.005. [DOI] [PubMed] [Google Scholar]
- 37.Zulet MA, Puchau B, Hermsdorff HH, Navarro C, Martínez JA. Dietary selenium intake is negatively associated with serum sialic acid and metabolic syndrome features in healthy young adults. Nutr Res. 2009;29:41–8. doi: 10.1016/j.nutres.2008.11.003. [DOI] [PubMed] [Google Scholar]
- 38.Puchau B, Zulet MA, Hermsdorff HH, Navarro-Blasco I, Martínez JA. Nail antioxidant trace elements are inversely associated with inflammatory markers in healthy young adults. Biol Trace Elem Res. 2010;133:304–12. doi: 10.1007/s12011-009-8443-5. [DOI] [PubMed] [Google Scholar]
- 39.Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition. 2010;26:534–41. doi: 10.1016/j.nut.2009.06.017. [DOI] [PubMed] [Google Scholar]
- 40.Puchau B, Zulet MA, Urtiaga G, Navarro-Blasco I, Martínez JA. Asymmetric dimethylarginine association with antioxidants intake in healthy young adults: A role as an indicator of metabolic syndrome features. Metabolism. 2009;58:1483–8. doi: 10.1016/j.metabol.2009.04.037. [DOI] [PubMed] [Google Scholar]
- 41.Mutakin, Meiliana A, Wijaya A, Kobayashi K, Yamazaki C, Kameo S, et al. Association between selenium nutritional status and metabolic risk factors in men with visceral obesity. J Trace Elem Med Biol. 2013;27:112–6. doi: 10.1016/j.jtemb.2012.09.006. [DOI] [PubMed] [Google Scholar]
- 42.Ghayour-Mobarhan M, Taylor A, Lanham-New S, Lamb DJ, Nezhad MA, Kazemi-Bajestani SM, et al. Serum selenium and glutathione peroxidase in patients with obesity and metabolic syndrome. Pak J Nutr. 2008;7:112–7. [Google Scholar]
- 43.Skroza N, Proietti I, Bernardini N, La Viola G, Nicolucci F, Pampena R, et al. Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFα treatment. G Ital Dermatol Venereol. 2013;148:661–5. [PubMed] [Google Scholar]
- 44.Czernichow S, Vergnaud AC, Galan P, Arnaud J, Favier A, Faure H, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr. 2009;90:329–35. doi: 10.3945/ajcn.2009.27635. [DOI] [PubMed] [Google Scholar]
- 45.Basu A, Betts NM, Mulugeta A, Tong C, Newman E, Lyons TJ. Green tea supplementation increases glutathione and plasma antioxidant capacity in adults with the metabolic syndrome. Nutr Res. 2013;33:180–7. doi: 10.1016/j.nutres.2012.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Silva TR, Alves BC, Maturana MA, Spritzer PM. Healthier dietary pattern and lower risk of metabolic syndrome in physically active postmenopausal women. J Am Coll Nutr. 2013;32:287–95. doi: 10.1080/07315724.2013.826111. [DOI] [PubMed] [Google Scholar]
- 47.Perez-Cornago A, Zulet MA, Martinez JA. Association between mood and diet quality in subjects with metabolic syndrome participating in a behavioural weight-loss programme: A cross-sectional assessment. Nutr Neurosci. 2015;18:137–44. doi: 10.1179/1476830514Y.0000000116. [DOI] [PubMed] [Google Scholar]
- 48.Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–74. doi: 10.1056/NEJMoa031049. [DOI] [PubMed] [Google Scholar]
- 49.Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, Majdzadeh R Caspian Study Group. Paediatric metabolic syndrome and associated anthropometric indices: The CASPIAN study. Acta Paediatr. 2006;95:1625–34. doi: 10.1080/08035250600750072. [DOI] [PubMed] [Google Scholar]
- 50.Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents – An IDF consensus report. Pediatr Diabetes. 2007;8:299–306. doi: 10.1111/j.1399-5448.2007.00271.x. [DOI] [PubMed] [Google Scholar]
- 51.Bates CJ, Prentice A, Cole TJ, van der Pols JC, Doyle W, Finch S, et al. Micronutrients: Highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over. Br J Nutr. 1999;82:7–15. doi: 10.1017/s0007114599001063. [DOI] [PubMed] [Google Scholar]
